To further verify the above results, we applied the TIMER and GEPIA2 website to obtain the expression status of FCGR3A across various cancer types of TCGA, and both showed that FCGR3A was highly expressed in most tumor tissues (Supplementary Figure S1). Here, FCGR3A is linked to neoplasm.